Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.
about
Tirapazamine: a novel agent targeting hypoxic tumor cellsThe chemopotentiation of cisplatin by the novel bioreductive drug AQ4NThe Radiation Stress Response: Of the People, By the People and For the People.Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia.SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours.Prospects for bioreductive drug development.Enhancement of the anti-tumour effect of cyclophosphamide by the bioreductive drugs AQ4N and tirapazamine.TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules.Is there a role for tirapazamine in the treatment of cervical cancer?The effect of tirapazamine (SR-4233) alone or combined with chemotherapeutic agents on xenografted human tumours.Manipulation and exploitation of the tumour environment for therapeutic benefit.Enhancement of the antitumor effect of cyclophosphamide with the hypoxia-selective cytotoxin NLCQ-1 against murine tumors and human xenografts.Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome.Effects of bioreductive agents, tirapazamine and mitomycin C, on quiescent cell populations in solid tumors, evaluated by micronucleus assay.
P2860
Q28302710-8A7E079C-4A18-4EA8-91C1-03E167B1EDDAQ28346061-D298698F-E2DA-4DE5-821B-E8D7FD1FA19EQ30151428-D0EB7C69-F3C1-4078-9749-F85A61663F39Q33279493-C0B32FB2-A387-4EBA-9EB1-587A45D33388Q35976983-780A021D-9B12-49B0-9342-EF3B95D92A40Q36181210-63C1E211-F026-46D0-AAC3-981A931B3752Q36621361-7393B7A1-505E-4A52-886F-C367328B3109Q37700855-7AC69143-82B3-431E-99C6-85091E54AFD2Q38049169-3B4F12FB-C613-4AE9-8926-3B4F7395B80DQ39995096-1A2931DD-25DB-4AF6-89A9-528690596F46Q40620925-B9CF0B15-72C4-485D-A7E5-FBAE7D267F0CQ44204636-E5AAE52E-032A-47F4-A78A-2D48B62B1615Q47769995-5BEB25BB-78C3-4E4A-9805-B309475BD474Q55260558-9D249654-CD86-41D4-B3EB-5F2CF5D9C4F0
P2860
Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.
description
1992 nî lūn-bûn
@nan
1992 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.
@ast
Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.
@en
type
label
Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.
@ast
Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.
@en
prefLabel
Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.
@ast
Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.
@en
P2093
P356
P1476
Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.
@en
P2093
P304
P356
10.1093/JNCI/84.3.187
P407
P577
1992-02-01T00:00:00Z